Neoleukin Therapeutics Inc. (NLTX) NASDAQ
$3.55 (0.05) (-1.25%)
Market Cap: $33.32M
As of 12/08/23 04:00 PM EST. Market closed.
Neoleukin Therapeutics Inc. (NLTX)
NASDAQ
$3.55
(0.05) (-1.25%)
Market Cap: $33.32M
As of 12/08/23 04:00 PM EST. Market closed.
Add to Portfolio
neoleukin therapeutics, inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. the company's lead product candidate is nl-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (il)-2/il-15 for the treatment of various types of cancer, including renal cell carcinoma ... read more
neoleukin therapeutics, inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. the company's lead product candidate is nl-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (il)-2/il-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. the company was formerly known as aquinox pharmaceuticals, inc. and changed its name to neoleukin therapeutics, inc. in august 2019. neoleukin therapeutics, inc. was founded in 2003 and is headquartered in seattle, washington. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
66
Address
.
PRICE CHART FOR NEOLEUKIN THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.52
Previous Close
$3.59
Days Range
$3.46 - $3.65
52 week range
$2.03 - $4.70
Volume
16,913
Avg. Volume (30 days)
23,702
Market Cap
$33.32M
Dividend Yield
-
P/E
-
Shares Outstanding
9,397,901
Open
$3.52
Previous Close
$3.59
Days Range
$3.46 - $3.65
52 week range
$2.03 - $4.70
Volume
16,913
Avg. Volume (30 days)
23,702
Market Cap
$33.32M
Dividend Yield
-
P/E
-
Shares Outstanding
9,397,901
FINANCIAL STATEMENTS FOR NEOLEUKIN THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR NEOLEUKIN THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| BAKER BROS. ADVISORS LP | Director | Aug 17, 2023 | Buy | $0.69 | 166,942 | 115,617 | 5,612,949 | Aug 17, 2023, 05:08 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 16, 2023 | Buy | $0.68 | 229,600 | 156,254 | 5,458,724 | Aug 17, 2023, 05:08 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 15, 2023 | Buy | $0.63 | 1,888,800 | 1,191,616 | 5,246,614 | Aug 17, 2023, 05:08 PM |
| Smith Sean Michael | Interim CFO, Prin Acct Off | Aug 11, 2023 | Sale | $0.62 | 1,323 | 818 | 21,637 | Aug 14, 2023, 04:06 PM |
| Patel Priti | Former Chief Medical Officer | Apr 03, 2023 | Sale | $0.69 | 3,769 | 2,608 | 37,313 | Apr 04, 2023, 08:51 PM |
| Smith Sean Michael | Principal Accounting Officer | Feb 02, 2023 | Sale | $0.60 | 3,316 | 1,980 | 15,960 | Feb 03, 2023, 04:33 PM |
| Patel Priti | Chief Medical Officer | Feb 02, 2023 | Sale | $0.60 | 14,380 | 8,588 | 31,082 | Feb 03, 2023, 04:32 PM |
| Smith Sean Michael | Principal Accounting Officer | Aug 10, 2022 | Sale | $0.99 | 1,655 | 1,641 | 6,776 | Aug 12, 2022, 05:24 PM |
| Patel Priti | Chief Medical Officer | May 02, 2022 | Sale | $1.22 | 5,538 | 6,749 | 6,462 | May 03, 2022, 07:16 PM |
| DRACHMAN JONATHAN G | President and CEO | Aug 24, 2021 | Buy | $6.11 | 100,000 | 611,100 | 2,348,686 | Aug 26, 2021, 07:08 PM |
| DRACHMAN JONATHAN G | President and CEO | Aug 25, 2021 | Buy | $6.45 | 50,000 | 322,450 | 25,000 | Aug 26, 2021, 07:08 PM |
| Walkey Carl | Senior Vice President | Jun 16, 2021 | Sale | $10.19 | 600 | 6,114 | 1,352,489 | Jun 17, 2021, 09:46 PM |
| Walkey Carl | Senior Vice President | Jun 08, 2021 | Sale | $11.00 | 600 | 6,600 | 1,353,739 | Jun 09, 2021, 05:22 PM |
| Walkey Carl | Senior Vice President | May 26, 2021 | Sale | $10.00 | 600 | 6,000 | 1,354,939 | May 26, 2021, 07:37 PM |
| Walkey Carl | Senior Vice President | May 19, 2021 | Sale | $10.63 | 600 | 6,378 | 1,355,539 | May 21, 2021, 05:24 PM |
| Walkey Carl | Senior Vice President | Apr 26, 2021 | Sale | $13.00 | 600 | 7,800 | 1,359,562 | Apr 27, 2021, 07:59 PM |
| Walkey Carl | Senior Vice President | Apr 21, 2021 | Sale | $11.98 | 1,800 | 21,564 | 1,360,162 | Apr 22, 2021, 05:11 PM |
| Walkey Carl | Senior Vice President | Apr 14, 2021 | Sale | $12.22 | 1,800 | 21,996 | 1,361,962 | Apr 16, 2021, 07:08 PM |
| Walkey Carl | Senior Vice President | Apr 07, 2021 | Sale | $12.02 | 1,800 | 21,636 | 1,363,762 | Apr 08, 2021, 07:06 PM |
| Walkey Carl | Senior Vice President | Mar 31, 2021 | Sale | $11.96 | 1,800 | 21,528 | 1,366,162 | Apr 02, 2021, 05:21 PM |
| Walkey Carl | Senior Vice President | Mar 24, 2021 | Sale | $11.95 | 1,800 | 21,516 | 1,367,962 | Mar 24, 2021, 06:48 PM |
| Walkey Carl | Senior Vice President | Mar 22, 2021 | Sale | $12.00 | 600 | 7,200 | 1,369,762 | Mar 24, 2021, 06:48 PM |
| Walkey Carl | Senior Vice President | Mar 17, 2021 | Sale | $11.36 | 1,200 | 13,632 | 1,370,362 | Mar 18, 2021, 08:45 PM |
| Ho Robert | Chief Financial Officer | Mar 17, 2021 | Sale | $11.01 | 6,497 | 71,556 | 21,503 | Mar 18, 2021, 08:44 PM |
| Walkey Carl | Senior Vice President | Mar 10, 2021 | Sale | $11.97 | 1,800 | 21,540 | 1,371,562 | Mar 11, 2021, 04:14 PM |
| Walkey Carl | Senior Vice President | Mar 03, 2021 | Sale | $11.87 | 1,800 | 21,360 | 1,373,362 | Mar 04, 2021, 06:52 PM |
| Walkey Carl | Senior Vice President | Feb 25, 2021 | Sale | $13.00 | 600 | 7,800 | 1,375,162 | Feb 25, 2021, 08:17 PM |
| Walkey Carl | Senior Vice President | Feb 24, 2021 | Sale | $12.14 | 1,800 | 21,852 | 1,375,762 | Feb 25, 2021, 08:17 PM |
| Walkey Carl | Senior Vice President | Feb 17, 2021 | Sale | $12.70 | 2,400 | 30,480 | 1,377,562 | Feb 18, 2021, 04:20 PM |
| Walkey Carl | Senior Vice President | Feb 10, 2021 | Sale | $14.20 | 3,000 | 42,600 | 1,379,962 | Feb 12, 2021, 04:23 PM |
| Walkey Carl | Senior Vice President | Feb 05, 2021 | Sale | $14.00 | 600 | 8,400 | 1,382,962 | Feb 09, 2021, 04:41 PM |
| Walkey Carl | Senior Vice President | Feb 03, 2021 | Sale | $13.23 | 2,400 | 31,752 | 1,383,562 | Feb 05, 2021, 04:51 PM |
| BAKER BROS. ADVISORS LP | Director | Jul 07, 2020 | Buy | $15.25 | 424,000 | 6,466,000 | 3,501,691 | Dec 23, 2020, 07:31 PM |
| Redmile Group, LLC | 10% Owner | Apr 01, 2020 | Buy | $11.10 | 42,500 | 471,630 | 4,021,579 | Apr 06, 2020, 07:04 PM |
| Redmile Group, LLC | 10% Owner | Mar 31, 2020 | Buy | $10.31 | 30,000 | 309,389 | 3,979,079 | Apr 06, 2020, 07:04 PM |
| Redmile Group, LLC | 10% Owner | Mar 30, 2020 | Buy | $9.94 | 32,500 | 322,910 | 3,949,079 | Apr 06, 2020, 07:04 PM |
| Redmile Group, LLC | 10% Owner | Mar 27, 2020 | Buy | $9.21 | 50,000 | 460,395 | 3,916,579 | Apr 06, 2020, 07:04 PM |
| Redmile Group, LLC | 10% Owner | Apr 02, 2020 | Buy | $11.37 | 39,300 | 446,958 | 4,051,045 | Apr 06, 2020, 07:04 PM |
| Redmile Group, LLC | 10% Owner | Apr 02, 2020 | Sale | $11.31 | 9,834 | 111,214 | 4,041,311 | Apr 06, 2020, 07:04 PM |
| Redmile Group, LLC | 10% Owner | Apr 01, 2020 | Sale | $11.08 | 9,834 | 108,940 | 4,011,945 | Apr 06, 2020, 07:04 PM |
| DRACHMAN JONATHAN G | President and CEO | Dec 20, 2019 | Buy | $8.40 | 119,047 | 999,995 | 2,198,686 | Dec 20, 2019, 06:53 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 20, 2019 | Buy | $8.40 | 3,017,542 | 25,347,352 | 12,872,664 | Dec 20, 2019, 05:16 PM |
| DRACHMAN JONATHAN G | See Remarks | Sep 11, 2019 | Buy | $3.30 | 136,436 | 449,898 | 584,428 | Sep 11, 2019, 05:39 PM |
| DRACHMAN JONATHAN G | See Remarks | Sep 10, 2019 | Buy | $3.08 | 36,742 | 113,290 | 447,992 | Sep 11, 2019, 05:39 PM |
| DRACHMAN JONATHAN G | See Remarks | Sep 09, 2019 | Buy | $2.85 | 76,822 | 218,559 | 411,250 | Sep 11, 2019, 05:39 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 07, 2019 | Buy | $3.05 | 289,725 | 882,884 | 10,105,159 | Aug 08, 2019, 05:00 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 06, 2019 | Buy | $2.85 | 81,800 | 232,731 | 9,839,472 | Aug 08, 2019, 05:00 PM |
| LEVITT DANIEL J | Director | May 14, 2018 | Option Exercise | $10.56 | 3,906 | 41,247 | 3,906 | May 16, 2018, 07:45 PM |
| LEVITT DANIEL J | Director | May 14, 2018 | Sale | $12.67 | 3,906 | 49,489 | 0 | May 16, 2018, 07:45 PM |
| MacKenzie Lloyd | Chief Operating Officer | Mar 15, 2018 | Option Exercise | $10.56 | 1,302 | 13,749 | 1,302 | Mar 19, 2018, 05:58 PM |
| MacKenzie Lloyd | Chief Operating Officer | Mar 15, 2018 | Sale | $14.63 | 1,302 | 19,049 | 0 | Mar 19, 2018, 05:58 PM |
| Main David | President and CEO | Jun 05, 2017 | Option Exercise | $9.60 | 3,625 | 34,800 | 75,155 | Jun 05, 2017, 07:00 PM |
| Main David | President and CEO | Jun 02, 2017 | Option Exercise | $9.60 | 6,000 | 57,600 | 77,530 | Jun 05, 2017, 07:00 PM |
| Main David | President and CEO | Jun 01, 2017 | Option Exercise | $9.60 | 6,000 | 57,600 | 77,530 | Jun 05, 2017, 07:00 PM |
| Main David | President and CEO | Jun 05, 2017 | Sale | $13.16 | 3,625 | 47,696 | 71,530 | Jun 05, 2017, 07:00 PM |
| Main David | President and CEO | Jun 02, 2017 | Sale | $13.59 | 6,000 | 81,560 | 71,530 | Jun 05, 2017, 07:00 PM |
| Main David | President and CEO | Jun 01, 2017 | Sale | $13.00 | 6,000 | 77,988 | 71,530 | Jun 05, 2017, 07:00 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 09, 2017 | Buy | $17.18 | 398,062 | 6,836,813 | 9,764,459 | Jan 09, 2017, 06:46 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Sep 20, 2016 | Buy | $12.25 | 2,783,605 | 34,110,452 | 9,404,467 | Sep 21, 2016, 04:28 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Mar 16, 2016 | Buy | $8.00 | 361,755 | 2,893,570 | 6,928,119 | Mar 16, 2016, 06:56 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Mar 15, 2016 | Buy | $7.98 | 106,538 | 850,484 | 6,601,891 | Mar 16, 2016, 06:56 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Mar 15, 2016 | Buy | $7.88 | 3,374 | 26,582 | 781,421 | Mar 16, 2016, 06:56 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 22, 2016 | Buy | $10.72 | 50,315 | 539,465 | 6,422,989 | Jan 26, 2016, 06:53 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 22, 2016 | Buy | $10.78 | 1,887 | 20,345 | 765,980 | Jan 26, 2016, 06:53 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 26, 2016 | Buy | $10.81 | 77,639 | 839,524 | 6,502,773 | Jan 26, 2016, 06:53 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 25, 2016 | Buy | $11.11 | 10,945 | 121,576 | 6,432,847 | Jan 26, 2016, 06:53 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 20, 2016 | Buy | $9.48 | 112,034 | 1,062,538 | 6,375,941 | Jan 20, 2016, 07:12 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 19, 2016 | Buy | $9.11 | 73,016 | 665,474 | 6,274,969 | Jan 20, 2016, 07:12 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 19, 2016 | Buy | $9.08 | 5,029 | 45,642 | 750,354 | Jan 20, 2016, 07:12 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 15, 2016 | Buy | $8.47 | 84,670 | 717,201 | 6,204,630 | Jan 15, 2016, 05:37 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 14, 2016 | Buy | $8.13 | 107,983 | 878,410 | 6,128,358 | Jan 15, 2016, 05:37 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 14, 2016 | Buy | $8.17 | 9,970 | 81,472 | 735,198 | Jan 15, 2016, 05:37 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 14, 2016 | Buy | $8.17 | 9,970 | 81,472 | 735,198 | Jan 15, 2016, 05:13 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 15, 2016 | Buy | $8.47 | 84,670 | 717,201 | 6,204,630 | Jan 15, 2016, 05:13 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Jan 14, 2016 | Buy | $8.13 | 107,983 | 878,410 | 6,128,358 | Jan 15, 2016, 05:13 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Sep 10, 2015 | Buy | $15.50 | 2,213,469 | 34,308,770 | 6,022,104 | Sep 11, 2015, 04:11 PM |
| BAKER BROS. ADVISORS LP | 10% Owner | Sep 10, 2015 | Buy | $15.50 | 266,563 | 4,131,727 | 725,228 | Sep 11, 2015, 04:11 PM |
| Mitchell David Chilton | VP Global Regulatory & Quality | Aug 24, 2015 | Buy | $17.81 | 3,575 | 63,671 | 3,575 | Aug 26, 2015, 04:48 PM |
| MacKenzie Lloyd | VP Technical Operations | Aug 12, 2015 | Option Exercise | $5.76 | 35,887 | 206,709 | 35,887 | Aug 14, 2015, 08:39 PM |
| MacKenzie Lloyd | VP Technical Operations | Aug 12, 2015 | Sale | $18.67 | 35,887 | 670,010 | 0 | Aug 14, 2015, 08:39 PM |
| Alam Kamran | CFO, Vice President Finance | Aug 12, 2015 | Option Exercise | $5.76 | 29,079 | 167,495 | 29,079 | Aug 14, 2015, 08:36 PM |
| Alam Kamran | CFO, Vice President Finance | Aug 12, 2015 | Sale | $18.67 | 29,079 | 542,905 | 0 | Aug 14, 2015, 08:36 PM |
| Mitchell David Chilton | VP Global Regulatory & Quality | Aug 11, 2015 | Buy | $24.36 | 1,600 | 38,976 | 1,600 | Aug 13, 2015, 08:20 PM |
| PFIZER INC | 10% Owner | Aug 10, 2015 | Sale | $26.47 | 259,927 | 6,880,295 | 1,235,312 | Aug 12, 2015, 04:30 PM |
| JOHNSON & JOHNSON | 10% Owner | Aug 11, 2015 | Sale | $20.74 | 1,283,366 | 26,617,011 | 100,000 | Aug 12, 2015, 12:24 PM |
| JOHNSON & JOHNSON | 10% Owner | Aug 10, 2015 | Sale | $31.66 | 231,455 | 7,327,865 | 1,383,366 | Aug 12, 2015, 12:24 PM |
| JOHNSON & JOHNSON | 10% Owner | Mar 12, 2014 | Buy | $11.00 | 272,727 | 2,999,997 | 1,664,821 | Feb 03, 2015, 12:05 PM |
| JOHNSON & JOHNSON | 10% Owner | Dec 17, 2014 | Sale | $7.58 | 1,593 | 12,075 | 1,342,094 | Dec 18, 2014, 10:43 AM |
| JOHNSON & JOHNSON | 10% Owner | Dec 16, 2014 | Sale | $7.63 | 6,507 | 49,648 | 1,343,687 | Dec 18, 2014, 10:43 AM |
| JOHNSON & JOHNSON | 10% Owner | Dec 11, 2014 | Sale | $7.50 | 1,355 | 10,163 | 1,353,839 | Dec 15, 2014, 08:48 PM |
| JOHNSON & JOHNSON | 10% Owner | Dec 12, 2014 | Sale | $7.51 | 3,645 | 27,374 | 1,350,194 | Dec 15, 2014, 08:48 PM |
| JOHNSON & JOHNSON | 10% Owner | Dec 10, 2014 | Sale | $7.70 | 1,300 | 10,010 | 1,355,194 | Dec 10, 2014, 09:13 PM |
| JOHNSON & JOHNSON | 10% Owner | Dec 09, 2014 | Sale | $7.73 | 5,000 | 38,650 | 1,356,494 | Dec 10, 2014, 09:13 PM |
| JOHNSON & JOHNSON | 10% Owner | Dec 08, 2014 | Sale | $7.69 | 2,000 | 15,380 | 1,361,494 | Dec 10, 2014, 09:13 PM |
| JOHNSON & JOHNSON | 10% Owner | Dec 03, 2014 | Sale | $7.75 | 1,627 | 12,609 | 1,377,767 | Dec 05, 2014, 06:57 PM |
| JOHNSON & JOHNSON | 10% Owner | Dec 05, 2014 | Sale | $7.78 | 4,200 | 32,676 | 1,363,494 | Dec 05, 2014, 06:57 PM |
| JOHNSON & JOHNSON | 10% Owner | Dec 04, 2014 | Sale | $7.76 | 10,073 | 78,166 | 1,367,694 | Dec 05, 2014, 06:57 PM |
| JOHNSON & JOHNSON | 10% Owner | Dec 01, 2014 | Sale | $7.54 | 1,200 | 9,048 | 1,379,394 | Dec 03, 2014, 02:24 PM |
| JOHNSON & JOHNSON | 10% Owner | Nov 26, 2014 | Sale | $7.60 | 500 | 3,800 | 1,380,594 | Nov 26, 2014, 04:18 PM |
| JOHNSON & JOHNSON | 10% Owner | Nov 25, 2014 | Sale | $7.80 | 1,500 | 11,700 | 1,381,094 | Nov 26, 2014, 04:18 PM |
| JOHNSON & JOHNSON | 10% Owner | Nov 24, 2014 | Sale | $8.02 | 4,000 | 32,080 | 1,382,594 | Nov 24, 2014, 05:45 PM |
| JOHNSON & JOHNSON | 10% Owner | Nov 21, 2014 | Sale | $8.25 | 2,400 | 19,800 | 1,386,594 | Nov 24, 2014, 05:45 PM |
| JOHNSON & JOHNSON | 10% Owner | Nov 20, 2014 | Sale | $8.21 | 3,100 | 25,451 | 1,388,994 | Nov 24, 2014, 05:45 PM |
| PFIZER INC | 10% Owner | Mar 12, 2014 | Buy | $11.00 | 272,727 | 2,999,997 | 1,235,330 | Mar 14, 2014, 03:27 PM |
| Main David | President and CEO | Mar 12, 2014 | Option Exercise | $11.00 | 9,459 | 104,049 | 71,530 | Mar 14, 2014, 03:21 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| BAKER BROS. ADVISORS LP | Director | 08/17/2023 | 115,617 |
| BAKER BROS. ADVISORS LP | Director | 08/16/2023 | 156,254 |
| BAKER BROS. ADVISORS LP | Director | 08/15/2023 | 1,191,616 |
| Smith Sean Michael | Interim CFO, Prin Acct Off | 08/11/2023 | 818 |
| Patel Priti | Former Chief Medical Officer | 04/03/2023 | 2,608 |
| Smith Sean Michael | Principal Accounting Officer | 02/02/2023 | 1,980 |
| Patel Priti | Chief Medical Officer | 02/02/2023 | 8,588 |
| Smith Sean Michael | Principal Accounting Officer | 08/10/2022 | 1,641 |
| Patel Priti | Chief Medical Officer | 05/02/2022 | 6,749 |
| DRACHMAN JONATHAN G | President and CEO | 08/24/2021 | 611,100 |
| DRACHMAN JONATHAN G | President and CEO | 08/25/2021 | 322,450 |
| Walkey Carl | Senior Vice President | 06/16/2021 | 6,114 |
| Walkey Carl | Senior Vice President | 06/08/2021 | 6,600 |
| Walkey Carl | Senior Vice President | 05/26/2021 | 6,000 |
| Walkey Carl | Senior Vice President | 05/19/2021 | 6,378 |
| Walkey Carl | Senior Vice President | 04/26/2021 | 7,800 |
| Walkey Carl | Senior Vice President | 04/21/2021 | 21,564 |
| Walkey Carl | Senior Vice President | 04/14/2021 | 21,996 |
| Walkey Carl | Senior Vice President | 04/07/2021 | 21,636 |
| Walkey Carl | Senior Vice President | 03/31/2021 | 21,528 |
| Walkey Carl | Senior Vice President | 03/24/2021 | 21,516 |
| Walkey Carl | Senior Vice President | 03/22/2021 | 7,200 |
| Walkey Carl | Senior Vice President | 03/17/2021 | 13,632 |
| Ho Robert | Chief Financial Officer | 03/17/2021 | 71,556 |
| Walkey Carl | Senior Vice President | 03/10/2021 | 21,540 |
| Walkey Carl | Senior Vice President | 03/03/2021 | 21,360 |
| Walkey Carl | Senior Vice President | 02/25/2021 | 7,800 |
| Walkey Carl | Senior Vice President | 02/24/2021 | 21,852 |
| Walkey Carl | Senior Vice President | 02/17/2021 | 30,480 |
| Walkey Carl | Senior Vice President | 02/10/2021 | 42,600 |
| Walkey Carl | Senior Vice President | 02/05/2021 | 8,400 |
| Walkey Carl | Senior Vice President | 02/03/2021 | 31,752 |
| BAKER BROS. ADVISORS LP | Director | 07/07/2020 | 6,466,000 |
| Redmile Group, LLC | 10% Owner | 04/01/2020 | 471,630 |
| Redmile Group, LLC | 10% Owner | 03/31/2020 | 309,389 |
| Redmile Group, LLC | 10% Owner | 03/30/2020 | 322,910 |
| Redmile Group, LLC | 10% Owner | 03/27/2020 | 460,395 |
| Redmile Group, LLC | 10% Owner | 04/02/2020 | 446,958 |
| Redmile Group, LLC | 10% Owner | 04/02/2020 | 111,214 |
| Redmile Group, LLC | 10% Owner | 04/01/2020 | 108,940 |
| DRACHMAN JONATHAN G | President and CEO | 12/20/2019 | 999,995 |
| BAKER BROS. ADVISORS LP | Director | 12/20/2019 | 25,347,352 |
| DRACHMAN JONATHAN G | See Remarks | 09/11/2019 | 449,898 |
| DRACHMAN JONATHAN G | See Remarks | 09/10/2019 | 113,290 |
| DRACHMAN JONATHAN G | See Remarks | 09/09/2019 | 218,559 |
| BAKER BROS. ADVISORS LP | Director | 08/07/2019 | 882,884 |
| BAKER BROS. ADVISORS LP | Director | 08/06/2019 | 232,731 |
| LEVITT DANIEL J | Director | 05/14/2018 | 41,247 |
| LEVITT DANIEL J | Director | 05/14/2018 | 49,489 |
| MacKenzie Lloyd | Chief Operating Officer | 03/15/2018 | 13,749 |
| MacKenzie Lloyd | Chief Operating Officer | 03/15/2018 | 19,049 |
| Main David | President and CEO | 06/05/2017 | 34,800 |
| Main David | President and CEO | 06/02/2017 | 57,600 |
| Main David | President and CEO | 06/01/2017 | 57,600 |
| Main David | President and CEO | 06/05/2017 | 47,696 |
| Main David | President and CEO | 06/02/2017 | 81,560 |
| Main David | President and CEO | 06/01/2017 | 77,988 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/09/2017 | 6,836,813 |
| BAKER BROS. ADVISORS LP | 10% Owner | 09/20/2016 | 34,110,452 |
| BAKER BROS. ADVISORS LP | 10% Owner | 03/16/2016 | 2,893,570 |
| BAKER BROS. ADVISORS LP | 10% Owner | 03/15/2016 | 850,484 |
| BAKER BROS. ADVISORS LP | 10% Owner | 03/15/2016 | 26,582 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/22/2016 | 539,465 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/22/2016 | 20,345 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/26/2016 | 839,524 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/25/2016 | 121,576 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/20/2016 | 1,062,538 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/19/2016 | 665,474 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/19/2016 | 45,642 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/15/2016 | 717,201 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/14/2016 | 878,410 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/14/2016 | 81,472 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/14/2016 | 81,472 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/15/2016 | 717,201 |
| BAKER BROS. ADVISORS LP | 10% Owner | 01/14/2016 | 878,410 |
| BAKER BROS. ADVISORS LP | 10% Owner | 09/10/2015 | 34,308,770 |
| BAKER BROS. ADVISORS LP | 10% Owner | 09/10/2015 | 4,131,727 |
| Mitchell David Chilton | VP Global Regulatory & Quality | 08/24/2015 | 63,671 |
| MacKenzie Lloyd | VP Technical Operations | 08/12/2015 | 206,709 |
| MacKenzie Lloyd | VP Technical Operations | 08/12/2015 | 670,010 |
| Alam Kamran | CFO, Vice President Finance | 08/12/2015 | 167,495 |
| Alam Kamran | CFO, Vice President Finance | 08/12/2015 | 542,905 |
| Mitchell David Chilton | VP Global Regulatory & Quality | 08/11/2015 | 38,976 |
| PFIZER INC | 10% Owner | 08/10/2015 | 6,880,295 |
| JOHNSON & JOHNSON | 10% Owner | 08/11/2015 | 26,617,011 |
| JOHNSON & JOHNSON | 10% Owner | 08/10/2015 | 7,327,865 |
| JOHNSON & JOHNSON | 10% Owner | 03/12/2014 | 2,999,997 |
| JOHNSON & JOHNSON | 10% Owner | 12/17/2014 | 12,075 |
| JOHNSON & JOHNSON | 10% Owner | 12/16/2014 | 49,648 |
| JOHNSON & JOHNSON | 10% Owner | 12/11/2014 | 10,163 |
| JOHNSON & JOHNSON | 10% Owner | 12/12/2014 | 27,374 |
| JOHNSON & JOHNSON | 10% Owner | 12/10/2014 | 10,010 |
| JOHNSON & JOHNSON | 10% Owner | 12/09/2014 | 38,650 |
| JOHNSON & JOHNSON | 10% Owner | 12/08/2014 | 15,380 |
| JOHNSON & JOHNSON | 10% Owner | 12/03/2014 | 12,609 |
| JOHNSON & JOHNSON | 10% Owner | 12/05/2014 | 32,676 |
| JOHNSON & JOHNSON | 10% Owner | 12/04/2014 | 78,166 |
| JOHNSON & JOHNSON | 10% Owner | 12/01/2014 | 9,048 |
| JOHNSON & JOHNSON | 10% Owner | 11/26/2014 | 3,800 |
| JOHNSON & JOHNSON | 10% Owner | 11/25/2014 | 11,700 |
| JOHNSON & JOHNSON | 10% Owner | 11/24/2014 | 32,080 |
| JOHNSON & JOHNSON | 10% Owner | 11/21/2014 | 19,800 |
| JOHNSON & JOHNSON | 10% Owner | 11/20/2014 | 25,451 |
| PFIZER INC | 10% Owner | 03/12/2014 | 2,999,997 |
| Main David | President and CEO | 03/12/2014 | 104,049 |
Load More Insider Transactions
FUNDS WITH A POSITION IN NEOLEUKIN THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 12,152,509 | 0.05% | 217.98% | Other |
| BAKER BROS. ADVISORS LP | 1,894,217 | 0.05% | 55.08% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 937,223 | 0.00112% | Exited | Other |
| BLACKROCK INC. | 483,948 | 0.00001% | Exited | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 310,000 | 0.00278% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 301,057 | 0.00003% | Exited | Other |
| RENAISSANCE TECHNOLOGIES LLC | 163,447 | 0.0011% | New | Other |
| BLACKROCK INC. | 96,613 | 0.00001% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 62,885 | 0.00003% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR NEOLEUKIN THERAPEUTICS INC
STOCK BUYBACKS FOR NEOLEUKIN THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
-1.16%
1Q
03/31/2023
0.16%
2Q
12/31/2022
0.40%
3Q
09/30/2022
0.46%
4Q
06/30/2022
0.55%
5Q
03/31/2022
0.66%
6Q
12/31/2021
0.73%
7Q
09/30/2021
0.76%
8Q
06/30/2021
0.87%
9Q
03/31/2021
1.02%
10Q
12/31/2020
1.64%
11Q
09/30/2020
2.56%
12Q
06/30/2020
12.38%
13Q
03/31/2020
12.89%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEOLEUKIN THERAPEUTICS INC
LOADING...